Literature DB >> 20206248

Potential of an injectable chitosan/starch/beta-glycerol phosphate hydrogel for sustaining normal chondrocyte function.

Jatuporn Ngoenkam1, Atchariya Faikrua, Sukkid Yasothornsrikul, Jarupa Viyoch.   

Abstract

An injectable hydrogel for chondrocyte delivery was developed by blending chitosan and starch derived from various sources with beta-glycerol phosphate (beta-GP) in the expectation that it would retain a liquid state at room temperature and gel at raised temperatures. Rheological investigation indicated that the system consisting of chitosan derived from crab shell and corn starch at 4:1 by weight ratio (1.53%, w/v of total polymers), and 6.0% (w/v) beta-GP (C/S/GP system) exhibited the sharpest sol-gel transition at 37+/-2 degrees C. The C/S/GP hydrogel was gradually degraded by 67% within 56 days in PBS containing 0.02 mg/ml lysozyme. The presence of starch in the system increased the water absorption of the hydrogel when compared to the system without starch. SEM observation revealed to the interior structure of the C/S/GP hydrogel having interconnected pore structure (average pore size 26.4 microm) whereas the pore size of the hydrogel without starch was 19.8 microm. The hydrogel also showed an ability to maintain chondrocyte phenotype as shown by cell morphology and expression of type II collagen mRNA and protein. In vivo study revealed that the gel was formed rapidly and localized at the injection site. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206248     DOI: 10.1016/j.ijpharm.2010.02.028

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Improving the stability of chitosan-gelatin-based hydrogels for cell delivery using transglutaminase and controlled release of doxycycline.

Authors:  Christian J Tormos; Carol Abraham; Sundararajan V Madihally
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

2.  Strong and Elastic Chitosan/Silk Fibroin Hydrogels Incorporated with Growth-Factor-Loaded Microspheres for Cartilage Tissue Engineering.

Authors:  Qing Min; Danlei Tian; Yuchen Zhang; Congcong Wang; Ying Wan; Jiliang Wu
Journal:  Biomimetics (Basel)       Date:  2022-04-07

Review 3.  A narrative overview of utilizing biomaterials to recapitulate the salient regenerative features of dental-derived mesenchymal stem cells.

Authors:  Sevda Pouraghaei Sevari; Sahar Ansari; Alireza Moshaverinia
Journal:  Int J Oral Sci       Date:  2021-06-30       Impact factor: 6.344

4.  Efficacy of thermosensitive chitosan/β-glycerophosphate hydrogel loaded with β-cyclodextrin-curcumin for the treatment of cutaneous wound infection in rats.

Authors:  Yong Zhao; Jia-Guo Liu; Wei-Min Chen; Ai-Xi Yu
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

5.  Sustained Releasing of Methotrexate from Injectable and Thermosensitive Chitosan-Carbon Nanotube Hybrid Hydrogels Effectively Controls Tumor Cell Growth.

Authors:  Leyla Saeednia; Li Yao; Kim Cluff; Ramazan Asmatulu
Journal:  ACS Omega       Date:  2019-02-22

6.  Evaluating Non-Conventional Chitosan Sources for Controlled Release of Risperidone.

Authors:  Sara Garcinuño; Inmaculada Aranaz; Concepción Civera; Concepción Arias; Niuris Acosta
Journal:  Polymers (Basel)       Date:  2022-03-26       Impact factor: 4.329

7.  Synergetic integrations of bone marrow stem cells and transforming growth factor-β1 loaded chitosan nanoparticles blended silk fibroin injectable hydrogel to enhance repair and regeneration potential in articular cartilage tissue.

Authors:  Dong Zheng; Tong Chen; Long Han; Songwei Lv; Jianjian Yin; Kaiyuan Yang; Yuji Wang; Nanwei Xu
Journal:  Int Wound J       Date:  2022-03-09       Impact factor: 3.099

8.  Evaluation of chitosan-GP hydrogel biocompatibility in osteochondral defects: an experimental approach.

Authors:  Edivaldo A N Martins; Yara M Michelacci; Raquel Y A Baccarin; Bruno Cogliati; Luis C L C Silva
Journal:  BMC Vet Res       Date:  2014-08-27       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.